| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $18K | -80.9% |
| Cost of Revenue | $8K | -85.5% |
| Gross Profit | $10K | -74.4% |
| R&D Expense | $8.2M | +89.8% |
| SG&A Expense | $8.1M | +372.7% |
| Operating Income | -$16.3M | -258.3% |
| Interest Expense | $19K | -99.7% |
| Pre-tax Income | -$17.1M | +26.0% |
| Net Income | -$17.1M |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.2M | — |
| Accounts Receivable | $18K | -2.1% |
| Current Assets | $14.1M | — |
| Total Assets | $15.1M | — |
| Current Liabilities | $1.5M | +5106.9% |
| Total Liabilities | $1.5M | +5203.4% |
| Stockholders' Equity | $13.5M | — |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.1M | +0.0% |
| Capital Expenditures | $118K | +0.0% |
| Investing Cash Flow | -$118K | +0.0% |
| Financing Cash Flow | $4.6M | +0.0% |
| Free Cash Flow | -$4.2M | +0.0% |
| +26.0% |
| EPS (Basic) | -$0.68 | +62.2% |
| EPS (Diluted) | -$0.68 | +62.2% |